REGISTERED
on 05 Jul 2022
Last Applicant/ Owned by
4455 GENESEE STREET
BUFFALO
NY
14225
Serial Number
88780609 filed on 31st Jan 2020
Registration Number
6782829 registered on 05th Jul 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Logo Mark Trademark Information
aspirin-based analgesics; antipyretic and anti-inflammatory oral preparations in the form of liquid-filled capsules; oral preparations in the form of liquid-filled capsules for the treatment of pain, fever, arthritis, rheumatoid arthritis, osteoarthritis, cardiovascular disease prevention and cancer prevention
Classification Information
Class [005]
Pharmaceutical Products
aspirin-based analgesics; antipyretic and anti-inflammatory oral preparations in the form of liquid-filled capsules; oral preparations in the form of liquid-filled capsules for the treatment of pain, fever, arthritis, rheumatoid arthritis, osteoarthritis, cardiovascular disease prevention and cancer prevention
First Use Date in General
14th Aug 2021
First Use Date in Commerce
14th Aug 2021
Mark Details
Serial Number
No 88780609
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 11577.001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
01.15.13 -
Single wave of water
01.15.25 -
Other natural phenomena and observable events
06.03.07 -
Waterfalls
10.09.01 -
Medicines and nonmedical products in tablet, capsule or powder form; suppositories
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Sep 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 05th Jul 2022 | REGISTERED-PRINCIPAL REGISTER |
| 05th Jul 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 03rd Jun 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 02th Jun 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 02th Jun 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 02th Jun 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 01st Jun 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 05th Jan 2022 | SU - NON-FINAL ACTION - WRITTEN |
| 05th Jan 2022 | NON-FINAL ACTION E-MAILED |